Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China

BACKGROUND: The data in the real-world setting on breast pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) for hormone receptor–positive, human epidermal growth factor receptor-2-negative (HR+, HER2−) breast cancer (BC) is limited. The present study aims to screen for some pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Dandan, Jie, Qiu, Wu, Yihao, Xu, Yuhao, Hong, Weimin, Meng, Xuli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520808/
https://www.ncbi.nlm.nih.gov/pubmed/36175898
http://dx.doi.org/10.1186/s12957-022-02787-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520808/
https://www.ncbi.nlm.nih.gov/pubmed/36175898
http://dx.doi.org/10.1186/s12957-022-02787-9

Ejemplares similares